Time since starting PCSK9 inhibitors | Median% LDL-C reduction | Range |
---|---|---|
2 weeks (n=34*) | 39.5% | 6-71% |
3 months (n=34*) | 49.0% | 4 - 78% |
6 months (n=25) | 47.0% | 21- 76% |
12 months (n=11) | 50.0% | 30-94% |
*Two patients have high triglyceride levels therefore unable to obtain values for LDL-C. Total cholesterol (TC) reduction at 3 months ranged from 36%–66% in these two patients.